Raajit Rampal, MD, PhD, reviews the case of a 67-year-old man with primary myelofibrosis.
EP. 1: Overview: A 67-Year-Old Man with Primary Myelofibrosis
Raajit Rampal, MD, PhD, reviews the case of a 67-year-old man with primary myelofibrosis and shares his initial impressions.
EP. 2: Myelofibrosis and the COMFORT Trials
Dr Raajit Rampal assesses whether frontline treatment with ruxolitinib was appropriate in the presented patient case with supporting data from the COMFORT-I and -II clinical trials.
EP. 3: Myelofibrosis and its Clinical Phenotypes
An explanation of the clinical phenotypes of myelofibrosis.
EP. 4: Available Treatment Options for Myelofibrosis
An overview of the currently available treatment options in myelofibrosis.
EP. 5: Pacritinib in Myelofibrosis
Raajit Rampal, MD, PhD, reviews data from the PERSIST trials which support the use of pacritinib for myelofibrosis treatment.
EP. 6: Switching Between Therapies in Myelofibrosis
Dr Raajit Rampal discusses factors to consider when switching between therapies among patients with myelofibrosis.
EP. 7: Assessing Treatment Response in Myelofibrosis
Dr Raajit Rampal provides a brief overview of the criteria used to define response to myelofibrosis treatment.
EP. 8: Challenges in Treating Myelofibrosis
Raajit Rampal, MD, PhD, discusses the challenges and unmet needs of myelofibrosis treatments and highlights promising investigational therapies.
2 Clarke Drive Cranbury, NJ 08512